These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 307725)

  • 21. Resistance of mice to reinfection after E-aminocaproic acid treatment of primary influenza virus infection.
    Lozitsky VP; Puzis LE; Polyak RYa
    Acta Virol; 1988 Mar; 32(2):117-22. PubMed ID: 2899958
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of individual inhalation of aerosolized amantadine hydrochloride in mice infected with influenza virus A/Bethesda 10/63 (H2N2) and A/Hong Kong 1/68 (H3N2).
    Schmidt-Ruppin KH; Poncioni B
    Arzneimittelforschung; 1979; 29(4):652-9. PubMed ID: 582762
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect of interferon on subcellular changes in mouse lungs in experimental influenza virus infection].
    Chernukh AM; Kranchev AK
    Antibiotiki; 1966 Jul; 11(7):621-5. PubMed ID: 5997587
    [No Abstract]   [Full Text] [Related]  

  • 24. [Controlled change in the physiologic state of cell membranes as one of the principles of influence on the course of a pathologic process].
    Chernukh AM; Rudakova IS
    Biull Eksp Biol Med; 1967 Nov; 63(11):60-4. PubMed ID: 5633424
    [No Abstract]   [Full Text] [Related]  

  • 25. Seasonal and pandemic influenza preparedness: science and countermeasures.
    Fauci AS
    J Infect Dis; 2006 Nov; 194 Suppl 2():S73-6. PubMed ID: 17163392
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Circulation of HongKong A2 influenza virus in experimental animals during their infection with a virus-staphylococcus complex].
    Frolov AF; Shapiro AV; Gavrilov SV
    Mikrobiol Zh; 1977; 39(2):229-30. PubMed ID: 865333
    [No Abstract]   [Full Text] [Related]  

  • 27. [Antivirals for influenza].
    Leophonte P
    Bull Acad Natl Med; 2005 Feb; 189(2):341-55; discussion 355-7. PubMed ID: 16114863
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibitory effects of an antisense oligonucleotide in an experimentally infected mouse model of influenza A virus.
    Mizuta T; Fujiwara M; Abe T; Miyano-Kurosaki N; Yokota T; Shigeta S; Takaku H
    Biochem Biophys Res Commun; 2000 Dec; 279(1):158-61. PubMed ID: 11112432
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Therapeutic effect of aminoadamantane aerosol in experimental influenza of albino mice].
    Solovev VN; Tolmacheva NS
    Farmakol Toksikol; 1968; 31(6):714-6. PubMed ID: 5713584
    [No Abstract]   [Full Text] [Related]  

  • 30. Proteinase inhibitors from Streptomyces with antiviral activity.
    Serkedjieva J; Angelova L; Remichkova M; Ivanova I
    J Basic Microbiol; 2006; 46(6):504-12. PubMed ID: 17139614
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of influenza virus glycoproteins on the permeability of pulmonary capillaries in mice].
    Chuvakova ZK; Fursova LM; Isaeva ES; Dem'ianenko IV
    Vopr Virusol; 1985; 30(1):43-6. PubMed ID: 3993002
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Symptomatic therapy of influenza rhinitis in ferrets by topical application of compounds.
    Haff RF
    J Allergy; 1970 Mar; 45(3):163-77. PubMed ID: 5265049
    [No Abstract]   [Full Text] [Related]  

  • 33. [Comparative assessment of the therapeutic effect of inhitryl in tourniquet shock (experimental study)].
    Kharchenko VZ; Protsenko VA; Usharovich SM
    Farmakol Toksikol; 1977; 40(2):187-90. PubMed ID: 300691
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical biochemical indications for the use of proteolysis-inhibitors in periodontosis].
    Khomenko LA; Veremeenko KN
    Stomatologiia (Mosk); 1974; 53(2):13-5. PubMed ID: 4529338
    [No Abstract]   [Full Text] [Related]  

  • 35. Suppression of influenza virus replication in infected mice by protease inhibitors.
    Zhirnov OP; Ovcharenko AV; Bukrinskaya AG
    J Gen Virol; 1984 Jan; 65 ( Pt 1)():191-6. PubMed ID: 6198446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protective effect of protease inhibitors in influenza virus infected animals.
    Zhirnov OP; Ovcharenko AV; Bukrinskaya AG
    Arch Virol; 1982; 73(3-4):263-72. PubMed ID: 6184035
    [No Abstract]   [Full Text] [Related]  

  • 37. Highly potent and long-acting trimeric and tetrameric inhibitors of influenza virus neuraminidase.
    Watson KG; Cameron R; Fenton RJ; Gower D; Hamilton S; Jin B; Krippner GY; Luttick A; McConnell D; MacDonald SJ; Mason AM; Nguyen V; Tucker SP; Wu WY
    Bioorg Med Chem Lett; 2004 Mar; 14(6):1589-92. PubMed ID: 15006410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of antiviral treatment on the outcome of secondary bacterial pneumonia after influenza.
    McCullers JA
    J Infect Dis; 2004 Aug; 190(3):519-26. PubMed ID: 15243927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of protease inhibitors on the course of experimental influenza].
    Parusov VN; Lozitskiĭ VP; Mazhinskaia VP; Garmashova LM
    Patol Fiziol Eksp Ter; 1978; (2):16-9. PubMed ID: 307725
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.